Breaking News

Parexel Joins Exostar’s Life Sciences Community

By Kristin Brooks | March 11, 2014

Aims to expedite collaborations, reduce costs, and accelerate R&D

Parexel has joined Exostar’s Life Sciences Identity Hub, a community of more than 500 organizations that brings CROs, pharmaceutical manufacturers, and academic institutions together to help facilitate collaborations, reduce capital and operating expenditures, and enhance productivity in speeding time-to-market.
 
Through its Secure Access Manager (SAM) service offering, organizations connect to the cloud-based Exostar Life Sciences Identity Hub, opening the door to external partner collaboration through portals, applications, and information sharing. SAM verifies identities of individuals and permits access based on authentication methods and permissions defined by asset owners.  
 
“Parexel is committed to providing solutions that help its customers expedite time-to-market and achieve peak market penetration,” said Tom Johnson, Exostar’s senior director of Security and Collaboration Solutions for Life Sciences. “Our community allows them to more effectively achieve these objectives by creating a connected, integrated environment where intelligence can be shared seamlessly and securely.”
 

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.